Patient Organisation Grants support patient organisations’ independent education, awareness, and advocacy initiatives to strengthen patient voice and improve care across CSL Behring’s areas of interest and rare diseases.
Funder: CSL Behring
Due Dates: August 31, 2026 (Cycle 1) | December 4, 2026 (Cycle 2) | February 15, 2027 (Cycle 3) | April 30, 2027 (Cycle 4)
Funding Amounts: Financial support for independent awareness, education, and advocacy initiatives
Summary: Grants support patient organizations’ independent initiatives to strengthen patient voice and improve care in CSL’s areas of interest and rare diseases.
Key Information: Grants are for eligible organizations, not individuals; activities must be non-promotional and independent of CSL influence.
CSL Behring’s Patient Organisation Grants support independent awareness, education, and advocacy initiatives that empower patients and improve care and outcomes. Programs should demonstrate clear educational or advocacy value and meaningful benefit to patient communities. Priorities include earlier diagnosis, understanding treatment options, shared decision making, patient perspectives in health technology assessments, and addressing inequities in care.
Areas of interest include cardiovascular, renal, and iron-related conditions; acquired and congenital bleeding disorders; hereditary angioedema; chronic inflammatory demyelinating polyneuropathy (CIDP); and primary and secondary immunodeficiencies. CSL does not direct grant-funded content, speakers, materials, activities, or outcomes.